Business Segments Verici Dx plc
Equities
VRCI
GB00BM8HZD43
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6900 GBX | -4.83% |
|
-4.83% | -4.83% |
| 02-05 | EARNINGS AND TRADING: React sales increase; Arcontech profit declines | AN |
| 02-05 | Verici Dx's Tutivia Added as In-network Test Under BCBS Deal | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
In Vivo Diagnostic Substances | |||||
Development of Prognostic and Diagnostic Tests for Kidney Transplant Patients | - | - | - | 1.01M | 3.34M |
Total Assets | 20.31M | 13.79M | 14.3M | 7.44M | 7.49M |
Interest Expense | -105K | - | -5K | -29K | -22K |
CAPEX | -237K | -966K | -1.31M | -23K | -17K |
EBT | -7.1M | -8.33M | -11.41M | -8.73M | -5.87M |
D&A | 288K | 438K | 640K | 829K | 701K |
Operating Income | -7M | -8.33M | -11.46M | -8.87M | -6.11M |
Net Income | -7.1M | -8.33M | -11.41M | -8.73M | -5.87M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Total Assets | 2.23M | 2.79M | 3.98M | 3.45M | 2.93M |
- Stock Market
- Equities
- VRCI Stock
- Financials Verici Dx plc
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition